BMO Capital Starts RXO, Inc. (RXO) at Outperform, 'Well Positioned To Leverage TL Market Tightening'

BMO Capital analyst Fadi Chamoun initiates coverage on RXO, Inc. (NYSE: RXO) with a Outperform rating and a price target of $35.00.

The analyst comments "Initiating coverage of RXO at Outperform and a $35 price target. TL market tightness is back near prior-cycle peak levels, while AGP/load—which typically lags by three-to-four quarters—remains 60% below its prior peak. With a platform now handling more than 2x prior-cycle peak volumes and meaningful productivity gains, we see a path to ~$600 million of EBITDA this cycle. Upside to our base case could come from a higher peak multiple than our 10x assumption and a strong free cash flow outlook that supports accretive M&A optionality."

For an analyst ratings summary and ratings history on RXO, Inc. click here. For more ratings news on RXO, Inc. click here.

Shares of RXO, Inc. closed at $26.25 yesterday.

You May Also Be Interested In

• Oppenheimer Initiates Palisade Bio Inc. (PALI) at Outperform
• Oppenheimer Reiterates Outperform Rating on ServiceNow (NOW)
• Raymond James Starts Signet Jewelers (SIG) at Outperform